CARY, N.C., Dec. 6 /PRNewswire-FirstCall/ -- Sapiens International Corporation N.V. (Nasdaq and TASE: SPNS), a member of the Formula Group (Nasdaq: FORTY and TASE: FORT), today announced that it has paid the fourth and final installment of the principal amount of the convertible debentures (Series A) of the Company, in the amount of approximately $5.3 million. This completes Sapiens' payment of an aggregate amount of approximately $26.5 million of the principal amount of convertible debentures (Series A) of the Company.
The Company's announcement follows its recently released financial results for the third quarter of 2009, which showed the Company's twelfth consecutive quarter of operational profit and net income commencing from the third quarter of 2008.
Mr. Roni Al Dor, President & Chief Executive Officer of the Company said today:
"We view the final payment of the debentures as an important milestone in the lifecycle of the company. In the past few years, Sapiens has undergone a restructuring process in which we left no stone unturned in the company, and developed a business strategy which, I am happy to say, turned out to be a winning one. Payment of the debentures signifies, from our perspective, the character of Sapiens which does not compromise on business excellence while honoring all its obligations. Today, we are in a good financial position, and, after we have improved our bottom line, we are focussed on increasing our revenues by penetrating into new markets globally, as well as by exploring mergers and acquisitions with companies operating in synergetic fields. "
FOR ADDITIONAL INFORMATION:
Roni Giladi Roni Al-Dor Chief Financial Officer Chief Executive Officer Sapiens International Sapiens International Tel: +972-8-938-2721 Tel: +972-8-938-2721 E-mail: IR.Sapiens@sapiens.com E-mail: IR.Sapiens@sapiens.com
About Sapiens International
Sapiens International Corporation N.V. (Nasdaq and TASE: SPNS), a member of Formula Group (Nasdaq: FORTY and TASE: FORT), which is a member of the Emblaze Group (LSE: BLZ.L) is a leading global provider of proven IT solutions that modernize business processes and enable insurance organizations to adapt quickly to change. Sapiens' innovative solutions are widely recognized for their ability to cost-effectively align IT with the business demands for speed, flexibility and efficiency. Sapiens operates through its subsidiaries in North America, the United Kingdom, EMEA and Asia Pacific, and has partnerships with market leaders such as IBM and EDS. Sapiens' clients include AXA, ING, Liverpool Victoria, Menora Mivtachim, Norwich Union, Occidental Fire & Casualty, OneBeacon, Principal Financial Group, Santam and Texas Farm Bureau among others. For more information, please visit http://www.sapiens.com.
Except for historical information contained herein, the matters set forth in this release are forward-looking statements that are dependent on certain risks and uncertainties, including such factors, among others, as market acceptance, market demand, pricing, changing regulatory environment, changing economic conditions, risks in new product and service development, the effect of the Company's accounting policies, specific system configurations and software needs of individual customers and other risk factors detailed in the Company's SEC filings.
SOURCE Sapiens International Corporation N.V.
OR YEHUDA, Israel, Dec. 6 /PRNewswire-FirstCall/ -- Magic Software Enterprises Ltd. (Nasdaq: MGIC), a provider of application platforms and business and process integration solutions, today announced the sale of its Israel-based company office building, for the sum of approximately $5.2 million in cash.
Further details of the transaction and its impact on Magic Software's financials will be provided in the company's 2009 fourth quarter and year-end earnings release.
About Magic Software
Magic Software Enterprises Ltd. (Nasdaq: MGIC) is a global provider of multiple-mode application platform solutions - including Full Client, Rich Internet Applications (RIA) or Software-as-a-Service (SaaS) modes - and business and process integration solutions. Magic Software has offices in 10 countries and a presence in over 50, as well as a global network of ISV's, system integrators, value-added distributors and resellers, and consulting and OEM partners. The company's award-winning code-free solutions give partners and customers the power to leverage existing IT resources, enhance business agility and focus on core business priorities. Magic Software's technological approach, product roadmap and corporate strategy are recognized by leading industry analysts. Magic Software has partnerships with global IT leaders including SAP AG, salesforce.com, IBM and Oracle. For more information about Magic Software and its products and services, visit www.magicsoftware.com, and for more about our industry related news, business issues and trends, read the Magic Software Blog.
Except for the historical information contained herein, the matters discussed in this news release include forward-looking statements that may involve a number of risks and uncertainties. Actual results may vary significantly based upon a number of factors including, but not limited to, risks in product and technology development, market acceptance of new products and continuing product conditions, both here and abroad, release and sales of new products by strategic resellers and customers, and other risk factors detailed in the Company's most recent annual report and other filings with the Securities and Exchange Commission.
Company contact: Amit Birk Vice President M&A and General Counsel Magic Software Enterprises Ltd. Tel. +972 (0)3 538 9292 Email: abirk@magicsoftware.com
SOURCE Magic Software Enterprises Ltd.
SEOUL, Korea, Dec. 6 /PRNewswire/ -- RNL Bio Co., Ltd, (www.rnl.co.kr) a leading biopharmaceutical company specialized in adult stem cell therapeutics announced today that a 46-year-old female, Kang Sook Park's Multiple Sclerosis improved tremendously after receiving stem cell treatment. Park was suffering from MS (Multiple Sclerosis), an autoimmune disease that affects the central nervous system (brain and spinal cord).
Multiple Sclerosis is a disease in which the nerves of the central nervous system degenerate. MS can cause problems with muscle control and strength, vision, balance, feeling, and thinking. MS is caused by damage to the myelin sheath, the protective covering that surrounds nerve cells. When the myelin sheath is damaged, nerve impulses slow down or stop responding. From the many symptoms of MS, numbness or abnormal sensation in any area is predominant.
For the past 20 years, Park suffered from MS. For stem cell injection, she was admitted into Choyang Hospital of Regenerative Medicine in Yanji, China for three weeks. She received stem cells intravenously as well as intrathecally. The injections were given in five intervals -- a total of 1.2 billion cells.
Prior to stem cell treatment, Park suffered from Optic Neuritis -- a common symptom of MS. Some of the symptoms of Optic Neuritis include double vision, vision loss, and uncontrollable rapid eye movements. She was not able to recognize any writing due to her vision loss. After six months of receiving stem cell therapy, Park experienced phenomenal changes. Her vision improved drastically -- she was able to read. Furthermore, it also became possible for her to move her legs using her own muscular strength.
"My legs felt like hollow logs. They were so numb and stiff. However, after receiving stem cell treatment, I can actually feel my legs. I can also tell the difference in cold and warm temperatures. Stem cell therapy brought incredible changes to my physical condition," stated Kang Sook Park.
Park also added, "Receiving stem cell turned my life around. I feel like I am reborn. The fact that I am in this condition brings me new joy. I love the fact that I no longer need anyone's help to get from place to place. I would like to share my experience to others who may have this rare disease. I want to let others know that they can find hope through stem cell treatment, just the way I did."
Dr. Chang Won Kim reported Park's EMG findings before and after the stem cell treatment. "Patients who have an uncommon disease such as MS rarely show improvement or are completely cured. EMG results showed that Park's movement increased both in upper and lower limbs. Reduction in latency suggests that demyelination was also improved. It is extremely difficult for MS patients to use their own strength to even make small movements in the arms or legs. These changes in Park were possible through stem cell therapy."
President and CEO of RNL Bio, Dr. Jeong Chan Ra expressed, "The effective outcomes from stem cell treatment for rare diseases like Multiple Sclerosis can be used in the future. I will do my best to help improve the quality of life for people who are suffering from diseases like MS."
About RNL BIO CO., LTD.
RNL Bio is a premier biotechnology company focused on the research and development of adult derived stem cell therapies. RNL has conducted two Phase II clinical trials for Buerger's Disease as well as Osteoarthritis and one phase I trial for spinal cord injury. RNL is a publically traded company listed in the Korean Stock Exchange (Code 003190) and is expanding its operations throughout the world.
SOURCE RNL Bio Co., Ltd
WASHINGTON, Dec. 6 /PRNewswire-USNewswire/ -- Following is the daily "Profile America" feature from the U.S. Census Bureau:
(Logo: http://www.newscom.com/cgi-bin/prnh/20090226/CENSUSLOGO)
SUNDAY, DECEMBER 6: CITRUS FRUIT
Profile America -- Sunday, December 6th. Along with the colorful decorations and music, the pleasure of the holidays is also enhanced by the seasonal flow of fresh citrus fruit. In the past, children were said to dream of sugar plums and receiving an orange at Christmas was a major gift. Now, online and mail order catalogs feature boxes of perfect fruit for last-minute gifts. We each consume nearly 22 pounds of fresh citrus fruit a year -- including 10 pounds of oranges, over two pounds of grapefruit and nine pounds of lemons, limes, tangerines, and tangelos. Florida is the nation's leading citrus producer -- other major producers are California and Texas. You can find these and more facts about sports in America from the U.S. Census Bureau online at www.census.gov.
Sources: Statistical Abstract of the United States 2009, t. 210, 824
Profile America is produced by the Public Information Office of the U.S. Census Bureau. These daily features are available as produced segments, ready to air, on a monthly CD or on the Internet at http://www.census.gov (look under the "Newsroom" button).
SOURCE U.S. Census Bureau
CAPE CANAVERAL AFS, Fla., Dec. 5 /PRNewswire/ -- Launching its 36th successful mission in 36 months, a United Launch Alliance Delta IV rocket delivered the Air Force's third Wideband Global SATCOM (WGS-3) satellite into orbit at 8:47 p.m. EST, today. Launching from Space Launch Complex-37, WGS-3 joins the AF's two other WGS satellites, which both launched on ULA Atlas V vehicles on Oct. 10, 2007, and Apr. 3, 2009.
ULA was formed on Dec. 1, 2006, as a joint venture between Lockheed Martin and The Boeing Company, bringing together two of the launch industry's most experienced and successful teams -- the Lockheed Martin Atlas and Boeing Delta teams -- that had supported America's presence in space for more than 50 years. ULA's first launch occurred only 14 days later as a Delta II rocket launched NROL-21 from Vandenberg AFB, Calif., on Dec. 14, 2006. Since then, including today's mission, 35 more successful launches have occurred from CCAFS and VAFB including 11 Atlas V, 21 Delta II, and four Delta IV missions. It's noted that two of the four Delta IV missions were the Delta IV Heavy configuration, which launches three common booster cores at once.
"I couldn't be more proud of our nearly 3,850 ULA employees and our many government partners whom I'm privileged to work with at ULA," said Michael Gass, ULA President and Chief Executive Officer. "This team of people, with their combined expertise, is the reason for this sustained mission success. When we formed ULA in 2006, our primary mission was to the deliver the highest reliable products for assured access to space for our government and commercial customers. Launching successfully 36 times in our first 36 months of company history is a significant accomplishment as we celebrate our third anniversary."
The WGS-3 mission is the third installment of the Wideband Global SATCOM (WGS) system. The WGS satellites are important elements of a new high-capacity satellite communications system providing enhanced communications capabilities to America's troops in the field for the next decade and beyond. WGS enables more robust and flexible execution of Command and Control, Communications Computers, Intelligence, Surveillance, and Reconnaissance (C4ISR), as well as battle management and combat support information functions. WGS-3 augments the existing service of the WGS-1 and WGS-2 satellites by providing additional information broadcast capabilities.
Jim Sponnick, ULA Vice President, Delta Product Line stated, "ULA congratulates the Air Force and our mission partners on the successful launch of WGS-3. It was appropriate the Air Force, which was one of the primary customers ULA was created to support, was the customer for today's 36th launch in 36 months. WGS is also the first of the constellation of satellites to launch on both the Delta IV and Atlas V since the formation of ULA. This operational flexibility was a primary reason ULA was formed and we look forward to providing this capability to our government customers for decades to come."
The mission was the first time the Delta IV Medium+ (5,4) configuration was launched using a single common booster core with a Pratt & Whitney Rocketdyne RS-68 main engine, four Alliant Techsystems GEM 60 solid rocket motors, a PWR RL10B-2 upper stage engine and a five-meter diameter upper stage and composite payload fairing.
ULA's next launch, currently scheduled for Dec. 11, is a Delta II carrying the NASA Wide-field Infrared Survey Explorer (WISE) mission from Space Launch Complex-2 at VAFB with a launch window of 6:09-6:23 a.m., PST.
ULA program management, engineering, test and mission support functions are headquartered in Denver, Colo. Manufacturing, assembly and integration operations are located at Denver, Colo.; Decatur, Ala.; Harlingen, Texas; and San Diego, Calif. Launch operations are located at Cape Canaveral Air Force Station, Fla., and Vandenberg Air Force Base, Calif.
For more information on the ULA joint venture, visit the ULA Web site at www.ulalaunch.com, or call the ULA Launch Hotline at 1-877-ULA-4321 (852-4321).
SOURCE United Launch Alliance
More Press Releases
View Older Stories-
VELCADE(R) (Bortezomib) for Injection Based Regimens Result in Lower Costs and Less Patient Burden Than Other Commonly Used Multiple Myeloma Treatment Regimens
-
Manufacturer of Zhu Zhu Pets Confirms Safety of Mr. Squiggles Toy and Offers Validation of Testing Protocol
-
Giant Food Alerts Customers to Voluntary Recall of Del Monte College Inn No MSG Chicken Broth
-
Stop & Shop Alerts Customers to Voluntary Recall of Del Monte College Inn No MSG Chicken Broth
-
Raelian Iranian Leader Freed in Turkey
-
TERI Celebrates 3rd Annual Cuvee delle Vite to Benefit Center for Autistic Students, Adults
-
Innovative Strategies Improve Outcomes and Reduce Life-Threatening Complications Associated With Stem Cell Transplants
-
DNC Chairman Tim Kaine's Remarks, 11th Annual American Democracy Conference, December 3, 2009
-
SNT Cleaning Announces Name Change to Orofino Gold Corp.
-
Spectacular Launch for East Asian Games in Hong Kong
-
LA's Largest Free HIV Testing Event Set for Inglewood's Faithful Central Bible Church Sunday Dec. 6th
-
Celebs and Youth Rock out at World Premiere of Kyocera's Youth-Created 'All Access' Rock Documentary Featuring Public Enemy, Weezer, Blink-182 and More
-
Colgan Air, Inc. Releases November Performance Data
-
Pinnacle Airlines, Inc. Releases November Performance Data
-
Video B-Roll available via CNW - Japanese speed skating star carries the flame as Vancouver 2010 Olympic Torch Relay passes through Nova Scotia and Newfoundland & Labrador
-
www.BackgroundNow.com Announces Most Requested Court Documents for the Week Ending, Saturday, December 5th
-
DirectView Chosen to Facilitate Worldwide Broadcast of World Renowned Fetal Therapy Specialists From Around the World Gathering in Miami Including Pioneer Dr. Ruben Quintero
-
Salon Leau to Host 'Cuts for a Cause' to Raise Funds and Spread the Word About Childhood Terminal Illnesses
-
New Research Demonstrates Advances in Optimizing Treatments and Quality of Life for People With Hard-To-Treat Forms of Blood Cancer
-
Legislators of Color Urge Assault on Digital Divide; Say Status Quo is Unacceptable
-
Brower Piven Encourages Investors Who Have Losses in Excess of $500,000 From Investment in SunPower Corporation to Inquire About the Lead Plaintiff Position in Securities Fraud Class Action Lawsuit Be
-
Brower Piven Encourages Investors Who Have Losses in Excess of $300,000 From Investment in Northwest Pipe Company to Inquire About the Lead Plaintiff Position in Securities Fraud Class Action Lawsuit
-
Pivotal Data on ChemGenex's Omapro(TM) Highlighted at ASH Press Conference
-
Gloucester Pharmaceuticals' ISTODAX(R) Demonstrates Synergistic Activity with Velcade(R) in B-cell Non-Hodgkin's Lymphoma Cell Lines
-
Gloucester Pharmaceuticals Announces Final Results from ISTODAX(R) Phase 2 PTCL Study at ASH Annual Meeting
-
Allos Therapeutics Reports New Analyses of Data from Pivotal PROPEL Trial of FOLOTYN(TM) at 51st ASH Annual Meeting
-
DeSmogBlog.com: Hackers Attempt to Access Canadian Government Centre for Climate Modeling and Analysis
-
DeSmogBlog.com: Hackers Attempt to Access Canadian Government Centre for Climate Modeling and Analysis
-
Long-Term Soliris(R) Treatment Resulted in Sustained Reduction in Hemolysis and Improved Kidney Function in Japanese Patients with PNH
-
Cyclacel Reports Phase 2 Sapacitabine Data in Acute Myeloid Leukemia and Myelodysplastic Syndromes at 2009 ASH Annual Meeting
-
Advances in Genetic Understanding and Treatment Protocols Lead to Significant Progress in Leukemia and Myeloproliferative Disorders
-
Governor Rendell Breaks Ground on $36 Million Hotel, Office Tower; Says Coatesville's Revitalization Underway
-
Maximum Processing and RiskMeter Online Form Alliance
-
New Gene Findings Will Help Guide Treatment in Infant Leukemia
-
China (Shenzhen) International Finance Exhibition Builds the First Online 3D Virtual Exhibition Globally
-
H1N1 Pandemic a of Production Capacities
-
Crooner Releases New Version of "New York, New York"
-
Statement by the Federal Ombudsman for Victims of Crime
-
Alcoa 2009 Worldwide Month of Service: Alcoa Employees Rally in Record Numbers for Their Communities
-
Statement by the Federal Ombudsman for Victims of Crime
-
Say Goodbye to Boring Christmas Cards
-
Daily Variety Reports Zenescope Will Predict HORRORSCOPE
-
Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha
-
Taipei Floral Expo Butterfly Pavilion Appears on Stage-- One Earth, Many Magnificent Worlds
-
Hottest Holiday Toys High in Hazardous Chemicals: GoodGuide Finds Levels of Antimony & Chromium Above Legal Limits in Some of Season's Most Popular Toys
-
Striking Red Cross Workers Raise Public Awareness of Unsafe Working Conditions
-
Fans Find NCAA College Football Bowl Tickets Now With FanSnap
-
The Maui Celebrity Series at The Hard Rock launches on Maui
-
College Inn Initiates Voluntary Recall of Select Canned Chicken Broth Products due to Mislabeling
-
Government of Canada Tapping Important Chinese Canola Market
